We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
1901
DELISTED
Verve Therapeutics
VERV
| $89.2K | ﹤0.01% |
18,424
+4,417
| +32% | +$25.7K |
|
1902
Adtran
ADTN
$798M
| $88.2K | ﹤0.01% |
14,881
+4,426
| +42% | +$24.6K |
|
|
LGF.A
1903
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $88.1K | ﹤0.01% |
+11,257
| New | +$94.2K |
|
1904
SIGA Technologies
SIGA
$223M
| $87.5K | ﹤0.01% |
12,969
+2,408
| +23% | +$21K |
|
1905
Ouster
OUST
$2.29B
| $87.4K | ﹤0.01% |
+13,869
| New | +$132K |
|
1906
Gray Television
GTN
$407M
| $86.7K | ﹤0.01% |
16,169
+4,846
| +43% | +$25K |
|
1907
Titan International
TWI
$516M
| $84.5K | ﹤0.01% |
+10,396
| New | +$82.6K |
|
1908
Hertz
HTZ
$572M
| $84.5K | ﹤0.01% |
+25,599
| New | +$89.4K |
|
1909
CorMedix
CRMD
$617M
| $83.9K | ﹤0.01% |
+10,379
| New | +$56.2K |
|
|
TWKS
1910
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $83.6K | ﹤0.01% |
18,905
+6,503
| +52% | +$25K |
|
1911
ADT
ADT
$5.16B
| $83.3K | ﹤0.01% |
11,515
+36
| +0.3% | +$264 |
|
1912
Altimmune
ALT
$539M
| $82.4K | ﹤0.01% |
+13,421
| New | +$90.9K |
|
1913
Wheels Up
UP
$220M
| $82K | ﹤0.01% |
+1,695
| New | +$82.7K |
|
|
CTLP
1914
DELISTED
Cantaloupe
CTLP
| $81.7K | ﹤0.01% |
+11,037
| New | +$75.8K |
|
1915
LSB Industries
LXU
$881M
| $81K | ﹤0.01% |
+10,074
| New | +$80K |
|
1916
W&T Offshore
WTI
$545M
| $80.1K | ﹤0.01% |
37,272
+24,100
| +183% | +$53.6K |
|
1917
Bit Digital
BTBT
$484M
| $79.5K | ﹤0.01% |
22,646
+10,514
| +87% | +$34.9K |
|
1918
EVgo
EVGO
$200M
| $78.8K | ﹤0.01% |
19,031
+5,164
| +37% | +$19.7K |
|
1919
Nuvation Bio
NUVB
$2.24B
| $78.5K | ﹤0.01% |
34,259
+14,746
| +76% | +$45K |
|
|
CMRC
1920
Commerce.com Inc Series 1
CMRC
$224M
| $78K | ﹤0.01% |
+13,325
| New | +$87.9K |
|
|
NXDT
1921
NexPoint Diversified Real Estate Trust
NXDT
$281M
| $77.9K | ﹤0.01% |
+12,470
| New | +$74K |
|
|
DFTX
1922
Definium Therapeutics
DFTX
$5.73B
| $77.4K | ﹤0.01% |
+13,605
| New | +$94.6K |
|
1923
Beyond Meat
BYND
$288M
| $76.5K | ﹤0.01% |
+11,288
| New | +$71.4K |
|
|
NVRO
1924
DELISTED
NEVRO CORP.
NVRO
| $76.4K | ﹤0.01% |
+13,664
| New | +$95.6K |
|
|
URG
1925
Ur-Energy
URG
$485M
| $76.3K | ﹤0.01% |
+64,090
| New | +$76.6K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.